Qube Research & Technologies (QRT)
AZN icon

Qube Research & Technologies (QRT)’s AstraZeneca AZN Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$75.3M Buy
+382,048
New +$73.7M 0.08% 293
2025
Q4 		– Sell
-387,202
Closed -$67.9M – 3670
2025
Q3 		$59.4M Buy
387,202
+52,143
+16% +$7.89M 0.06% 397
2025
Q2 		$46.8M Buy
335,059
+223,244
+200% +$31.3M 0.05% 498
2025
Q1 		$16.4M Sell
111,815
-183,456
-62% -$26.5M 0.02% 847
2024
Q4 		$38.7M Sell
295,271
-156,435
-35% -$21.9M 0.05% 468
2024
Q3 		$70.4M Buy
451,706
+438,354
+3,283% +$70.8M 0.1% 243
2024
Q2 		$2.08M Sell
13,352
-30,439
-70% -$4.58M ﹤0.01% 1603
2024
Q1 		$5.93M Sell
43,791
-439,736
-91% -$58.2M 0.01% 1135
2023
Q4 		$65.1M Buy
483,527
+447,799
+1,253% +$58.2M 0.13% 200
2023
Q3 		$4.84M Sell
35,728
-251,207
-88% -$34.3M 0.01% 946
2023
Q2 		$41.1M Buy
286,935
+37,095
+15% +$5.46M 0.15% 193
2023
Q1 		$34.7M Buy
249,840
+8,892
+4% +$1.2M 0.15% 152
2022
Q4 		$32.7M Buy
240,948
+63,336
+36% +$7.94M 0.17% 143
2022
Q3 		$19.5M Buy
+177,612
New +$22.5M 0.12% 244
2020
Q4 		– Sell
-53,575
Closed -$5.87M – 1802
2020
Q3 		$5.87M Sell
53,575
-3,948
-7% -$439K 0.08% 308
2020
Q2 		$6.08M Buy
+57,523
New +$5.94M 0.09% 288
2020
Q1 		– Sell
-25,139
Closed -$2.51M – 1130
2019
Q4 		$2.51M Buy
25,139
+17,859
+245% +$1.68M 0.08% 301
2019
Q3 		$649K Buy
+7,280
New +$631K 0.43% 68
2018
Q2 		– Sell
-3,594
Closed -$251K – 834
2018
Q1 		$251K Buy
+3,594
New +$249K 0.1% 132

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Qube Research & Technologies (QRT)'s AZN Position: Q1 2026 in Review

Qube Research & Technologies (QRT) opened a new position in AstraZeneca (AZN) in Q1 2026: 382,048 shares worth $75.3M. The stake represents 0.08% of the portfolio and ranks #293 among its holdings. This is a return to the name: Qube Research & Technologies (QRT) previously reported a position in AZN as recently as Q3 2025.

Qube Research & Technologies (QRT) first reported a position in AZN in Q1 2018 and has held it in 19 quarters since. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Qube Research & Technologies (QRT) held 382,048 shares of AstraZeneca worth $75.3M as of Q1 2026.
  • AstraZeneca was a new Qube Research & Technologies (QRT) position in Q1 2026.
  • AstraZeneca made up 0.08% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #293 holding.
  • Qube Research & Technologies (QRT) first reported a position in AstraZeneca in Q1 2018 and has held it in 19 quarters since.
  • 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.